Transparency

An opinion piece in today’s Wall Street Journal misrepresents the facts about an annual meeting on scientific integrity at the EPA and the role of the EPA scientific integrity officer. Here are some details about what that meeting is and the role of federal agency scientific integrity officers. Read more >

Emails unsealed in a California lawsuit last week reveal that agribusiness giant Monsanto engaged in activities aimed at undermining efforts to evaluate a potential link between glyphosate—the active ingredient of the company’s popular herbicide Roundup—and cancer. The documents reveal the company’s plans to seed the scientific literature with a ghostwritten study, and its efforts to delay and prevent US government assessments of the product’s safety. Read more >

Happy sunshine week! It’s a week to celebrate one of the pillars of our democracy: access to information. This year’s sunshine week seems especially important because of the current Administration’s open hostility toward the media, which has been shining a light on the federal government’s operations day in and day out and illustrating the clear conflicts of interest of the corporate cabinet. Read more >

Back in October, I provided a comment at a public meeting for a National Academies of Science, Engineering and Medicine (NASEM) advisory committee that was set up to review the process to update the Dietary Guidelines for Americans. Their first charge was to write a report with recommendations on how the Dietary Guidelines Advisory Committee (DGAC) selection process could be improved to provide more transparency, minimize bias, and include committee members with a range of viewpoints. Read more >

In the midst of one of the mostabnormal presidential transitions in history, Congress is spending its last few weeks of session to wrap up pending business. One of the final remaining priorities for House and Senate leaders is the 21st Century Cures Act (Cures Act). Read more >